ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 48 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $2,488,000 | -45.0% | 217,328 | 0.0% | 0.02% | -40.5% |
Q1 2017 | $4,520,000 | 0.0% | 217,328 | 0.0% | 0.04% | -15.9% |
Q4 2016 | $4,520,000 | -36.5% | 217,328 | 0.0% | 0.04% | -32.3% |
Q3 2016 | $7,122,000 | +31.2% | 217,328 | 0.0% | 0.06% | +14.0% |
Q2 2016 | $5,427,000 | -67.7% | 217,328 | -57.7% | 0.06% | -63.2% |
Q3 2015 | $16,820,000 | -64.4% | 513,439 | -42.4% | 0.16% | -62.6% |
Q2 2015 | $47,233,000 | +86.1% | 891,688 | +1.4% | 0.41% | +96.2% |
Q1 2015 | $25,385,000 | +469.0% | 879,581 | +473.6% | 0.21% | +358.7% |
Q4 2014 | $4,461,000 | +129.5% | 153,350 | 0.0% | 0.05% | +91.7% |
Q3 2014 | $1,944,000 | -36.8% | 153,350 | 0.0% | 0.02% | -36.8% |
Q2 2014 | $3,078,000 | – | 153,350 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |